All our
news

Discuss, meet & share

Press releases

CORRECTION - Financial calendar 2025

24 February 2025

Intrasense (ISIN: FR0011179886), French expert in medical imaging solutions to assist and secure diagnosis, decision-making and therapeutic follow-up, announces the publication of its financial calendar for fiscal year 2025.

See the press release

Presentation of the Liflow® solution at the AI Action Summit event in Paris, as part of AI Action Week

12 February 2025

Intrasense (ISIN: FR0011179886 – Mnémo : ALINS), French expert in medical imaging solutions enhanced by AI assisting and securing diagnosis, decision-making and therapeutic follow-up, took part in the Side Event AI Action Summit, an event held on February 11, 2025 at the Grand Palais in Paris, as part of AI Action Week.

See the press release

Intrasense: 2024 annual sales of €2.2m, against a backdrop of transformation and strategic investment

6 February 2025

Intrasense (ISIN: FR0011179886 - Mnemo: ALINS), a French expert in AI-enhanced medical imaging solutions facilitating and securing diagnosis, decision-making and therapeutic follow-up, publishes its consolidated sales for the full year 2024.

See the press release

Intrasense presence at ECR (European Congress of Radiology) from February 26 to March 2, 2025 in Vienna

3 February 2025

Montpellier, France, February 3, 2025. Intrasense (ISIN: FR0011179886 – Mnémo : ALINS), French expert in medical imaging solutions enhanced by AI assisting and securing diagnosis, decision-making and therapeutic follow-up, announces its participation in the European Congress of Radiology (ECR) 2025, which will take place between February 26 and March 2 in Vienna (Austria).

See the press release

Financial calendar 2025

27 January 2025

Intrasense (ISIN: FR0011179886), French expert in medical imaging solutions to assist and secure diagnosis, decision-making and therapeutic follow-up, announces the publication of its financial calendar for fiscal year 2025.

See the press release

Our
conferences

WebinarsPodcasts

Our
articles

Do you want to receive our news in real time?

Subscribe